Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$970.7B
2,658M shares
52-week range
$279.10 – $366.50
96% from low
Sector
NATIONAL COMMERCIAL BANKS
Exchange
NYSE
CS
JPMorgan is a leading global financial services firm with operations in 66 countries and over 318,000 employees as of year-end 2025. Under the JPMorgan brands, the bank holding company boasts a $4.9 trillion balance sheet and $2.68 trillion in deposits, as of March 2026. The firm generates its revenue across three core operating segments: consumer and community banking, the commercial and investment bank, and asset and wealth management. It maintains the top global ranking in investment banking fees with an 8.4% market share, serves millions of consumers through its network of over 5,000 US branches, and manages over $7.1 trillion in client assets within its wealth and asset management franchise.
www.jpmorganchase.comNo one on the platform currently holds JPM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 688,350 | $202.5M |
| Bridgewater Associatesas of 2025-06-30 | 51,287 | $14.9M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-06 | $1.5000 | 2026-07-31 |
| 2026-04-06 | $1.5000 | 2026-04-30 |
| 2026-01-06 | $1.5000 | 2026-01-31 |
| 2025-10-06 | $1.5000 | 2025-10-31 |
| 2025-07-03 | $1.4000 | 2025-07-31 |
| 2025-04-04 | $1.4000 | 2025-04-30 |
| 2025-01-06 | $1.2500 | 2025-01-31 |
| 2024-10-04 | $1.2500 | 2024-10-31 |
| 2024-07-05 | $1.1500 | 2024-07-31 |
| 2024-04-04 | $1.1500 | 2024-04-30 |
No one on the platform has traded JPM yet.
| 2024-01-04 | $1.0500 | 2024-01-31 |
| 2023-10-05 | $1.0500 | 2023-10-31 |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $207.2B | +12.9% | $24.64 | $23.72–$26.09 | 14.7× | 9 |
| 2027 | $212.4B | +2.5% | $24.99 | $23.91–$25.64 | 14.5× | 12 |
| 2028 | $222.1B | +4.5% | $27.07 | $25.59–$29.87 | 13.4× | 8 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-14 | $5.59 | $7.59 | +35.8% |
| 2026-04-14 | $5.47 | $5.94 | +8.6% |
| 2026-01-13 | $4.85 | $4.63 | -4.5% |
| 2025-10-14 | $4.85 | $5.07 | +4.5% |
| 2025-07-15 | $4.48 | $4.96 | +10.7% |
| 2025-04-11 | $4.63 | $5.07 | +9.5% |
| 2025-01-15 | $4.09 | $4.81 | +17.6% |
| 2024-10-11 | $3.99 | $4.37 | +9.5% |
| $237.9B |
| — |
| CMCanadian Imperial Bank of Commerce | $122.40 | +1.24% | $113.4B | — |
| HSBCHSBC Holdings plc | $104.05 | -0.07% | $357.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
$SPY $QQQ $XLF $BAC $JPM god fucking forbid a single day of red
View on StockTwits ↗$JPM These massive banks are really going to start raking in the $$$ now through their trading platforms. Expect more record profits. They are already 2 steps ahead of the crowd. Now make it 3. $GS https://www.reuters.com/technology/trump-media-unveils-data-feed-businesses-tracking-truth-social-posts-2026-07-16/
View on StockTwits ↗Dell, JPMorgan, Merck All Mark New All-Time Highs $DELL $JPM $MRK https://www.benzinga.com/trading-ideas/movers/26/08/61197258/dell-jpmorgan-merck-all-mark-new-all-time-highs
View on StockTwits ↗$BTC.X old money coming for that new money $BLK $JPM $MSTR $SPY
View on StockTwits ↗$SPY Omg I understand now. Your own Bitcoin strategy has turned upside down. For the first time in 7 years I finally see it moving up. $BITO Your face is finally revealed. I can’t believe it’s been you this whole time ProShares.. here I am blaming $BLK $JPM and $HOOD but it’s been you begging the scenes this whole time.
View on StockTwits ↗$JPM BUY HIGH NOW !! Sell lower later ?? Must be that ??
View on StockTwits ↗Do those old money banks pay you 12% apy to hold? $STRC 💎🤲 $JPM $BAC $C $WFC
View on StockTwits ↗$REPL SOON $BMY buys this one for real , BY OCT 1 IMO. Someone is supporting sp here, $JPM ? Forgot but not so clear cut cost advantage for iova either: 1. Massive Hidden Ancillary Costs for Amtagvi The $563,000 list price for Amtagvi only covers the manufacturing of the cell therapy. For an insurance company, the all-in healthcare bill for Amtagvi is substantially higher because it is an intensive inpatient procedure: Surgery: Insurers must pay for a surgical procedure to harvest the patient’s tumor tissue.Inpatient Hospitalization: Patients are admitted to the hospital for high-dose "lymphodepletion" chemotherapy and subsequent IL-2 infusions to kickstart the cells. ICU Monitoring: Due to severe potential side effects like capillary leak syndrome, patients often require monitoring in an oncology intensive care unit. Result: The total medical claim for an Amtagvi treatment routinely clears $700,000 to $800,000 once hospital room, board, and specialist fees are added.😱
View on StockTwits ↗$SPY $JPM $BAC $XRP.X US Sentors flush with bank lobby contributions, banks otherwise illiquid
View on StockTwits ↗$DABRZZX.P $BX $GS $JPM $MS WHOA...$190B VALUATION: Databricks closes $5B funding round at $190B valuation Data and AI company Databricks announced it crossed a $7B revenue run-rate, delivering greater than 80% year-over-year growth during its Q2. Building on this momentum, the company closed a $5B strategic funding round at a $190B valuation. The investment will drive continued innovation across Lakebase, its serverless Postgres database built for AI agents, Genie, Databricks' AI coworker that turns business data into trusted answers and actions, and Unity AI Gateway, for multi-AI governance and cost controls, Databricks said in a statement. The round was led by Coatue, along with Blackstone (BX), MGX, accounts advised by T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc., and new investor Sixth Street Growth. Other new investors included BOND, Clearlake Capital, Point72, Premji Invest, and TPG alongside existing investors Andreessen Horowitz, Dragoneer, Fidelity Management & Research Company, Franklin Templeton, GIC, Growth Equity at Goldman Sachs Alternatives (GS), Insight Partners, J.P. Morgan Private Capital (JPM), Kinetic, Morgan Stanley Investment Management (MS), NEA, Ontario Teachers' Pension Plan, Temasek, Thrive Capital, and WCM Investment Management.
View on StockTwits ↗$CRCL Needs to test IPO price of 35 and let's see if $JPM tries to buy them out for 50-60 a share
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.